Lifeward (LFWD) Return on Capital Employed Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -896.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -896.00 |
| Dec 31, 2025 | -7,376.00 |
| Sep 30, 2025 | -13,478.00 |
| Jun 30, 2025 | -11,302.00 |
| Mar 31, 2025 | -8,220.00 |
| Dec 31, 2024 | -6,178.00 |
| Sep 30, 2024 | -1,122.00 |
| Jun 30, 2024 | -2,578.00 |
| Mar 31, 2024 | -2,407.00 |
| Dec 31, 2023 | -1,713.00 |
| Sep 30, 2023 | -1,842.00 |
| Jun 30, 2023 | -1,421.00 |
| Mar 31, 2023 | -1,265.00 |
| Dec 31, 2022 | -1,262.00 |
| Sep 30, 2022 | -832.00 |
| Jun 30, 2022 | -60.00 |
| Mar 31, 2022 | 847.00 |
| Dec 31, 2021 | 3,974.00 |
| Sep 30, 2021 | 5,952.00 |
| Jun 30, 2021 | 6,456.00 |
| Mar 31, 2021 | 7,329.00 |
| Dec 31, 2020 | 3,316.00 |
| Sep 30, 2020 | -7,105.00 |
| Jun 30, 2020 | -7,159.00 |
| Mar 31, 2020 | -6,630.00 |
| Dec 31, 2019 | -2,450.00 |
| Sep 30, 2019 | 61,058.00 |
| Jun 30, 2019 | 34,012.00 |
| Mar 31, 2019 | 20,245.00 |
| Dec 31, 2018 | 11,465.00 |
| Sep 30, 2018 | -42,968.00 |
| Jun 30, 2018 | -14,674.00 |
| Mar 31, 2018 | -4,435.00 |
| Dec 31, 2017 | 4,242.00 |
| Sep 30, 2017 | 6,079.00 |
| Jun 30, 2017 | -4,401.00 |
| Mar 31, 2017 | -6,533.00 |
| Dec 31, 2016 | -11,812.00 |
| Dec 31, 2015 | -6,250.00 |